Show simple item record

dc.contributor.authorWorld Health Organizationfr
dc.date.accessioned2012-06-17T01:44:53Z
dc.date.available2012-06-17T01:44:53Z
dc.date.created2011fr
dc.date.issued2011fr
dc.identifier.govdocWHO/HTM/HIV/11.1fr
dc.identifier.urihttps://apps.who.int/iris/handle/10665/70541
dc.descriptionWHO/HTM/HIV/11.1fr
dc.description8 p.fr
dc.language.isofrfr
dc.publisherGenève : Organisation mondiale de la Santéfr
dc.subject.meshHIV Infectionsfr
dc.subject.meshDidanosinefr
dc.subject.meshAcquired Immunodeficiency Syndromefr
dc.subject.otherAIDS and its Controlfr
dc.titleNote à l'intention des programmes nationaux de lutte contre le VIH/SIDA, des organismes d'achat et autres organisations partenaires sur la possibilité de ruptures de stock des comprimés tamponnés de didanosine à 25 mg et 50 mgfr
dc.subject.meshqualifierdrug therapyfr
dc.subject.meshqualifiersupply and distributionfr
dc.subject.meshqualifierprevention and controlfr


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record